Adage Capital Partners Portfolio holdings
AUM
$59.3B
This Quarter Return
-1.77%
1 Year Return
+26.26%
3 Year Return
+130.73%
5 Year Return
+248.99%
10 Year Return
+658.76%
AUM
$54B
AUM Growth
+$54B
(-5.6%)
Cap. Flow
-$972M
Cap. Flow
% of AUM
-1.8%
Top 10 Holdings %
Top 10 Hldgs %
28.72%
Holding
985
New
115
Increased
314
Reduced
359
Closed
149
Top Buys
| 1 |
Hubbell
HUBB
|
$208M |
| 2 |
Norfolk Southern
NSC
|
$145M |
| 3 |
Insmed
INSM
|
$137M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$136M |
| 5 |
Soleno Therapeutics
SLNO
|
$116M |
Top Sells
| 1 |
Bristol-Myers Squibb
BMY
|
$355M |
| 2 |
Royalty Pharma
RPRX
|
$334M |
| 3 |
McDonald's
MCD
|
$198M |
| 4 |
Union Pacific
UNP
|
$188M |
| 5 |
HES
Hess
HES
|
$182M |
Sector Composition
| 1 | Technology | 26.31% |
| 2 | Healthcare | 15% |
| 3 | Financials | 12.57% |
| 4 | Consumer Discretionary | 9.55% |
| 5 | Industrials | 8.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Seadrill
SDRL
$1.99B
| $105M | 0.19% | 4,200,535 +771,366 | +22% | +$19.3M |
|
102
Uber
UBER
$196B
| $105M | 0.19% | 1,436,100 -277,700 | -16% | -$20.2M |
|
103
Honeywell
HON
$139B
| $104M | 0.19% | 492,980 +135,896 | +38% | +$28.8M |
|
|
VRNA
104
Verona Pharma
VRNA
$9.16B
| $104M | 0.19% | 1,631,000 +1,292,575 | +382% | +$82.1M |
|
105
Lam Research
LRCX
$127B
| $103M | 0.19% | 1,412,020 +30,900 | +2% | +$2.25M |
|
106
Micron Technology
MU
$133B
| $102M | 0.19% | 1,170,903 -69,900 | -6% | -$6.07M |
|
107
Starbucks
SBUX
$100B
| $102M | 0.19% | 1,035,909 +50,853 | +5% | +$4.99M |
|
108
Blackrock
BLK
$175B
| $102M | 0.19% | 107,280 -24,700 | -19% | -$23.4M |
|
109
Wave Life Sciences
WVE
$1.53B
| $101M | 0.19% | 12,516,500 +2,894,396 | +30% | +$23.4M |
|
110
RB Global
RBA
$21.3B
| $100M | 0.19% | 1,000,000 +223,000 | +29% | +$22.4M |
|
111
Mondelez International
MDLZ
$79.5B
| $100M | 0.19% | 1,476,597 +478,700 | +48% | +$32.5M |
|
|
CNTA
112
Centessa Pharmaceuticals
CNTA
$2.25B
| $100M | 0.19% | 6,954,000 +1,834,973 | +36% | +$26.4M |
|
113
Arthur J. Gallagher & Co
AJG
$77.6B
| $99.1M | 0.18% | 287,103 -121,300 | -30% | -$41.9M |
|
114
Janux Therapeutics
JANX
$1.37B
| $98.7M | 0.18% | 3,654,574 +592,824 | +19% | +$16M |
|
115
Rockwell Automation
ROK
$38.6B
| $98.5M | 0.18% | 381,092 -35,801 | -9% | -$9.25M |
|
116
Ventas
VTR
$30.9B
| $97.9M | 0.18% | 1,424,000 +287,100 | +25% | +$19.7M |
|
117
Intel
INTC
$107B
| $97.6M | 0.18% | 4,298,685 +469,000 | +12% | +$10.7M |
|
118
Lockheed Martin
LMT
$106B
| $96.3M | 0.18% | 215,509 +174,438 | +425% | +$77.9M |
|
119
Palo Alto Networks
PANW
$127B
| $95.5M | 0.18% | 559,800 +11,900 | +2% | +$2.03M |
|
120
Entergy
ETR
$39.3B
| $95.4M | 0.18% | 1,116,404 +615,800 | +123% | +$52.6M |
|
121
MetLife
MET
$54.1B
| $94.6M | 0.18% | 1,178,326 +234,900 | +25% | +$18.9M |
|
122
Devon Energy
DVN
$22.9B
| $92.9M | 0.17% | 2,484,492 +320,700 | +15% | +$12M |
|
123
Altria Group
MO
$113B
| $92.8M | 0.17% | 1,545,532 -37,900 | -2% | -$2.27M |
|
124
Chord Energy
CHRD
$6.29B
| $91.3M | 0.17% | 810,381 -45,000 | -5% | -$5.07M |
|
125
Amphenol
APH
$133B
| $90M | 0.17% | 1,372,820 +103,900 | +8% | +$6.81M |
|